Muzaffer Serdar Deniz

9PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisToxicology (incl. clinical toxicology)Planning and decision making
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 25, 2026
Surgical extent, tumor size, and calcitonin levels in medullary thyroid carcinoma: impact on oncologic outcomes in a retrospective cohort study.

|Oct 13, 2025
Enhancing Diagnostic Accuracy in Bethesda III Thyroid Nodules: The Predictive Value of Serum IL-17A and Calprotectin

Muzaffer Serdar Deniz, Fatih Karataş, Öykü Uludağ

|Jul 30, 2025
A Comparative Study on the Multidimensional Features of Hereditary and Sporadic Medullary Thyroid Carcinoma Patients: A Single-Center Retrospective Study.

Muzaffer Serdar Deniz, Narin Nasiroglu Imga, Belma Ozlem Tural Balsak

|Nov 12, 2024
Effect of parathyroidectomy on serum inflammatory and metabolic dysfunction markers in patients with primary hyperparathyroidism.

Muzaffer Serdar Deniz, Nuriye Ozder, Omer Faik Ersoy

|Mar 15, 2024
Assessment of ChatGPT's adherence to ETA-thyroid nodule management guideline over two different time intervals 14 days apart: in binary and multiple-choice queries.

Muzaffer Serdar Deniz, Bagdagul Yuksel Guler

|Oct 12, 2023
Examining the impact of several factors including COVID-19 on thyroid fine-needle aspiration biopsy.

Muzaffer Serdar Deniz, Merve Dindar

Pageof 2

Frequent Collaborators

2 joint publications

Oya Topaloğlu

2 joint publications

Reyhan Ersoy

2 joint publications

Bekir Çakır

2 joint publications

Merve Dindar